Company intelligence
USDM Life Sciences
Evolving regulated operations to accelerate innovation.
About USDM Life Sciences
At USDM Life Sciences, we empower life sciences organizations to drive innovation through intelligent operations. By integrating AI, automation, and digital quality systems, we help biotech, pharma, and medical device companies deliver transformative results. Trusted by global technology leaders and life sciences organizations alike, we ensure seamless alignment between compliance and cutting-edge innovation. With tailored solutions that evolve regulated tasks, we enable our customers to achieve measurable outcomes with agility and confidence.
Verified activity
Signals from USDM Life Sciences
26 published signals
Products & Services
USDM Life Sciences built ProcessX with ServiceNow to address Abbott's unreliable software inventory and validation process issues.
Reported by USDM Life Sciences
Presence & Recognition
USDM Life Sciences is attending RAPS Convergence 2026 in Charlotte on September 15 to host a Lunch & Learn session on managing global UDI compliance and device registration strategies.
Reported by USDM Life Sciences
Research & Knowledge
USDM Life Sciences published an analysis written as Boston Scientific's cyberattack unfolded that breaks down why business impact, not just data exposure, is the real measure of cyber resilience.
Reported by Mark A Ohrvall
Partnerships
USDM Life Sciences helps life sciences organizations build a governed, defensible AI security posture before it is tested.
Reported by Mark A Ohrvall
Partnerships
USDM Life Sciences helps life sciences teams build governed AI defense internally in response to OpenAI's $1B pledge to train frontline cyber defenders.
Reported by Shelli P.
People
USDM Life Sciences is hiring a Senior Sales Executive for the MidAtlantic/Northeast region with an OTE salary of $231K to $346.6K and remote work.
Reported by USDM Life Sciences
Presence & Recognition
USDM Life Sciences is attending RAPS Convergence, The Blue Mountain Summit, and Veeva R&D and Quality Summit this fall.
Reported by USDM Life Sciences
Presence & Recognition
USDM Life Sciences is attending the RAPS conference in September 2026 to discuss what it means for registrations.
Reported by Shelli P.
Presence & Recognition
USDM Life Sciences announced that EUDAMED has landed, now at MVP status, with basic UDI-DI mandatory and unchangeable once set, new devices must register before market placement, and existing devices have a strict 6-month window.
Reported by John Weber
Products & Services
USDM Life Sciences developed and deployed ProcessX, a pre-validated GxP platform on ServiceNow with part 11 e-signatures, ALCOA Plus audit trails, and validated change control ready in 6-12 weeks.
Reported by USDM Life Sciences
Presence & Recognition
USDM Life Sciences is attending RAPS Convergence 2026 in Charlotte, NC for a Lunch & Learn on managing global UDI compliance and speaking sessions on EUDAMED, RIM implications, and sustained UDI operating models.
Reported by USDM Life Sciences
Partnerships
USDM Life Sciences partnered with Glean to pair Glean's Work AI platform with GxP validation, governed connectors, and life sciences-specific agents to help teams move from enterprise search to governed agents.
Reported by USDM Life Sciences
Strategy & Corporate Development
USDM Life Sciences supports medtech companies navigating multi-platform portfolio expansion, with Medtronic investing about 700 million dollars in a strategic partnership with Cornerstone Robotics to gain rights to distribute Sentire soft tissue surgical robot in China, Singapore, and Europe.
Reported by Shelli P.
Legal & Regulatory
USDM Life Sciences reported that DaVita agreed to pay $15M to settle claims tied to a breach affecting 2.7 million people.
Reported by Mark A Ohrvall
Presence & Recognition
USDM Life Sciences announced that EUDAMED has landed, now at MVP status, with basic UDI-DI mandatory and unchangeable once set, new devices must register before market placement, and existing devices have a strict 6-month window.
Reported by Mark A Ohrvall
Presence & Recognition
USDM Life Sciences and osapiens are attending the RAPS Convergence 2026 event in Charlotte on Tuesday, September 15, 2026, featuring a Lunch & Learn session on Global UDI Compliance and Registration Strategies led by Jay Crowley and Lionel Tussau.
Reported by John Weber
Research & Knowledge
USDM Life Sciences published a report breaking down the 4 patterns emerging across this year's life sciences cyber incidents, treating cyber resilience as business resilience rather than just an IT problem.
Reported by USDM Life Sciences
Presence & Recognition
USDM Life Sciences is attending The Blue Mountain Summit 2026 from September 15 to 17 in Durham, North Carolina.
Reported by USDM Life Sciences
Research & Knowledge
USDM Life Sciences researchers watched AI compress two weeks of attack work into 10 hours.
Reported by Shelli P.
Research & Knowledge
USDM Life Sciences published an analysis of Boston Scientific's cyberattack disrupting manufacturing and shipping with no restoration timeline yet.
Reported by John Weber
Presence & Recognition
USDM Life Sciences attended the Blue Mountain Summit 2026 in Durham, North Carolina from September 15 to 17.
Reported by John Weber
Presence & Recognition
USDM Life Sciences and osapiens are attending the RAPS Convergence 2026 event in Charlotte, featuring a Lunch & Learn on Global UDI Compliance and Registration Strategies.
Reported by Mark A Ohrvall
Presence & Recognition
USDM Life Sciences and osapiens are attending the RAPS Convergence 2026 event in Charlotte on Tuesday, September 15, 2026, featuring a Lunch & Learn session on Global UDI Compliance and Registration Strategies led by Jay Crowley and Lionel Tussau.
Reported by Jim Macdonell
Research & Knowledge
USDM Life Sciences published a report breaking down what cyber risk means for resilience planning, examining the impact of cyber incidents disrupting order processing and shipping.
Reported by John Weber